SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/2686C7AEC40D8EBF0768B51FC912C7E0658FF93018688694CA8D5818B3CC3F20570CEDEDFD4B79904D4EFB2E6B8B1629>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/2686C7AEC40D8EBF0768B51FC912C7E0658FF93018688694CA8D5818B3CC3F20570CEDEDFD4B79904D4EFB2E6B8B1629
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/2686C7AEC40D8EBF0768B51FC912C7E0658FF93018688694CA8D5818B3CC3F20570CEDEDFD4B79904D4EFB2E6B8B1629
http://www.w3.org/2000/01/rdf-schema#comment
"Expression in control and blank groups was similar at 3 and 6 months. Atorvastatin can inhibit VEGI and vascular endothelial growth factor expression to protect rats from diabetic retinopathy"
xsd:string
http://purl.uniprot.org/uniprot/#_2E5CE71025E080D0E97653482A92D5025399A168BE88B9CB2A28AD3B3DA7C28C49FD84492CB33D59A8458684408158A8
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/2686C7AEC40D8EBF0768B51FC912C7E0658FF93018688694CA8D5818B3CC3F20570CEDEDFD4B79904D4EFB2E6B8B1629
http://purl.uniprot.org/uniprot/Q8K3Y7
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/2686C7AEC40D8EBF0768B51FC912C7E0658FF93018688694CA8D5818B3CC3F20570CEDEDFD4B79904D4EFB2E6B8B1629
http://purl.uniprot.org/uniprot/#_Q8K3Y7-mappedCitation-26125742
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/2686C7AEC40D8EBF0768B51FC912C7E0658FF93018688694CA8D5818B3CC3F20570CEDEDFD4B79904D4EFB2E6B8B1629